www.cpexpharm.com
HOME
COMPANY PROFILE
MANAGEMENT
INVESTOR RELATIONS
OVERVIEW
CORPORATE GOVERNANCE
STOCK TRANSFER AGENT
SEC FILINGS
SECTION 16 FORMS
PRESENTATIONS/EVENTS
PUBLICATIONS
PRESS RELEASES
 ANNUAL REPORTS
CONTACT

 
 
  To view our documents, you must use software that is capable of opening PDF (portable document format) files. Our documents are compatible with Adobe® v6.0 and higher.
Get Acrobat Reader
 

Open publication
76 pages
 
 
FEBRUARY 18, 2010
CPEX PHARMACEUTICALS ANNOUNCES ARCADIA OPPORTUNITY MASTER FUND WITHDRAWS PREVIOUSLY STATED INTENTION TO SUBMIT SHAREHOLDER PROPOSALS AND NOMINATE DIRECTOR SLATE AT 2010 ANNUAL MEETING

ARCADIA RETAINS INTENT TO NOMINATE ONE DIRECTOR

 
FEBRUARY 01, 2010
CPEX PHARMACEUTICALS ANNOUNCES APPOINTMENT OF NEW CHIEF SCIENTIFIC OFFICER
 
JANUARY 08, 2010
CPEX PHARMACEUTICALS REPORTS ON SEC FILING BY ARCADIA CAPITAL ADVISORS
 

P I P E L I N E
 
P A R T N E R I N G
 
F A C T   S H E E T
 
 
[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]
 
CPEX PHARMACEUTICALS, INC.
2 HOLLAND WAY
EXETER NH 03833

TEL: 603.658.6100
FAX: 603.658.6101